Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01076660 · ClinicalTrials.gov registry record

Left Ventricular Structural Predictors of Sudden Cardiac Death

A clinical trial of Ischemic Cardiomyopathy and Non-ischemic Cardiomyopathy, sponsored by Johns Hopkins University.

Recruiting
Registry status
400
Enrollment target
2
Study locations

NCT01076660: Recruiting study of Ischemic Cardiomyopathy and Non-ischemic Cardiomyopathy, sponsored by Johns Hopkins University.

NCT01076660 is a study of Ischemic Cardiomyopathy and Non-ischemic Cardiomyopathy that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 400 participants, above the 339-participant average among 10 other Ischemic Cardiomyopathy trials with a reported enrollment target (18% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01076660, a study of Ischemic Cardiomyopathy and Non-ischemic Cardiomyopathy, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
400 participants
Enrollment target
2
Study locations

Study Summary

Sudden cardiac death (SCD) poses a significant health care challenge with high annual incidence and low survival rates. Implantable cardioverter defibrillators (ICDs) prevent SCD in patients with poor heart function. However, the critical survival benefit afforded by the devices is accompanied by short and long-term complications and a high economic burden. Moreover, in using current practice guidelines of reduced heart function, specifically left ventricular ejection fraction (LVEF)≤35%, as the main determining factor for patient selection, only a minority of patients actually benefit from ICD therapy (\<25% in 5 years). There is an essential need for more robust diagnostic approaches to SCD risk stratification. This project examines the hypothesis that structural abnormalities of the heart itself, above and beyond global LV dysfunction, are important predictors of SCD risk since they indicate the presence of the abnormal tissue substrate required for the abnormal electrical circuits and heart rhythms that actually lead to SCD. Information about the heart's structure will be obtained from cardiac magnetic resonance imaging and used in combination with a number of other clinical risk factors to see if certain characteristics can better predict patients at risk for SCD.

Primary Outcome

The first occurrence of an adjudicated appropriate ICD firing for ventricular tachycardia/ventricular fibrillation or cardiac death not treated by the ICD.

Study Locations (2)

Delaware

  • Christiana Care Health Services - Newark

Maryland

  • Johns Hopkins Medical Institutions - Baltimore

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2003-10
Est. Completion 2030-06
Johns Hopkins University

1,448 total trials

What NCT01076660 shows while recruiting

NCT01076660 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 339-participant average among 10 other Ischemic Cardiomyopathy trials with a reported enrollment target (18% higher).

The record links to 2 conditions, with Ischemic Cardiomyopathy appearing as the primary indexed condition, and to 0 interventions.

NCT01076660 reports a single indexed study location in Delaware, Maryland.

Frequently Asked Questions

What is clinical trial NCT01076660 about?

NCT01076660 is a clinical study titled "Left Ventricular Structural Predictors of Sudden Cardiac Death". Sudden cardiac death (SCD) poses a significant health care challenge with high annual incidence and low survival rates. Implantable cardioverter defibrillators (ICDs) prevent SCD in patients with poor heart function. However, the critical survival benefit afforded by the devices is accompanied by sh...

What is the current status of trial NCT01076660?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2003-10. Estimated completion is 2030-06.

What conditions does trial NCT01076660 study?

This clinical trial studies the following conditions: Ischemic Cardiomyopathy, Non-ischemic Cardiomyopathy.

Who is sponsoring clinical trial NCT01076660?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01076660 being conducted?

This trial has 2 study locations across Delaware, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Ischemic Cardiomyopathy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01076660's enrollment target sits among peer trials

400 2nd of 10 the highest of 10 other Ischemic Cardiomyopathy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Ischemic Cardiomyopathy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01076660, the US trial registry maintained by the National Library of Medicine. NCT01076660 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.